Chadrick Denlinger to Mutation
This is a "connection" page, showing publications Chadrick Denlinger has written about Mutation.
Connection Strength
0.092
-
Molecular basis of esophageal cancer development and progression. Surg Clin North Am. 2012 Oct; 92(5):1089-103.
Score: 0.071
-
Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer. Cancer Chemother Pharmacol. 2015 Jan; 75(1):17-23.
Score: 0.021